Pulmonary Circulation would become the valued journal in the field. We believe we are well on the way to achieving that goal.
This year, in Volume 7 of the journal, we are on track to publish more original research articles and reviews per issue, when compared with previous volumes. The editorial leadership team has been busy with more manuscripts submitted than in the past. This means many of you on the Editorial Board will receive more invitations to review manuscripts and support the continuing growth of the journal. We count on timely reviews to show authors that we are committed to a rapid response to their manuscripts. We count on our Editorial Board members to support the journal by submitting manuscripts to and reviewing manuscripts for the journal, reading and citing the published articles in the journal, and recommending the journal to colleagues and students.
Pulmonary Circulation will receive its first impact factor from Thomson Reuters this summer. The impact factor is a measure of a journal's citation influence in the broader literature. First, thank you to all who have submitted manuscripts to the journal, encouraged your colleagues to submit manuscripts, and read the journal. We also express thanks to authors who have cited research published in Pulmonary Circulation; our first impact factor will reflect the depth, breadth, and quality of the journal.
Again, we look to you, our readers and contributors, to help sustain the journal and take us to the next level. Please submit to us your most novel and significant original research articles in basic, translational, and clinical research; your comprehensive review articles on interesting topics related to pulmonary vascular disease; your highly novel (and rare) case reports; and your Leading Edge Perspectives (a new type of manuscript the editorial office is soliciting). Our Submissions Guidelines page outlines the requirements for each article type: https://us.sagepub.com/
